NCT05473130暂停不适用
Breethe Abiomed Recovery regisTry (BART)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- Abiomed Inc.
- 入组人数
- 1,000
- 主要终点
- Survival up to the hospital discharge
研究概览
简要总结
The BART Registry intended to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns, serve as a tool to measure and improve the quality of patient care and as a resource to inform us on the design of future studies.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •all adult subjects supported with Breethe Oxy-1 System
排除标准
- •subjects under 18 years of age
结局指标
主要结局
Survival up to the hospital discharge
时间窗: Up to the hospital discharge, an average of 2 months
次要结局
未报告次要终点
研究者
相似试验
撤回
不适用
Registry for the Use of HEMOBLAST Bellows in Total Knee ArthroplastyArthroplasty, Replacement, KneeNCT03772912Biom'Up France SAS
Unknown
不适用
Hyperbaric Oxygen Therapy RegistryAir or Gas EmbolismCarbon Monoxide PoisoningClostridial Myositis and Myonecrosis (Gas Gangrene)Crush Injury, Compartment Syndrome & Other Acute Traumatic IschemiasPeripheral Arterial Insufficiency and Central Retinal Artery OcclusionSevere AnemiaNecrotizing Soft Tissue InfectionsOsteomyelitis (Refractory)Decompression SicknessIntracranial AbscessDelayed Radiation Injury (Soft Tissue and Bony Necrosis)Compromised Grafts and FlapsAcute Thermal Burn InjuryIdiopathic Sudden Sensorineural Hearing LossNCT02483650U.S. Wound Registry5,000
终止
不适用
AVERT Plus Post-Market RegistryCoronary Artery DiseaseNCT02436642Osprey Medical, Inc20
撤回
不适用
Registry Study for the Use of HEMOBLAST™ Bellows in AbdominoplastyAbdominoplastyNCT03770195Biom'Up France SAS
已完成
不适用
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Atrial FibrillationNCT01165710Janssen Scientific Affairs, LLC10,179